School of Medicine
Showing 91-100 of 2,425 Results
-
Euan A. Ashley
Roger and Joelle Burnell Professor of Genomics and Precision Health, Arthur L. Bloomfield Professor of Medicine and Professor of Genetics, of Biomedical Data Science and, by courtesy, of Pathology
Current Research and Scholarly InterestsThe Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.
-
Rabia Aslam
Affiliate, Medicine - Primary Care and Population Health
BioM.D., University of California, Davis
B.A. in Public Health, University of California, Berkeley
My interest lies at the intersection of medicine and public health and I strive to work towards alleviating socioeconomic disparities in healthcare and education. -
Themistocles (Tim) Assimes
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsGenetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes
-
Danielle Francoise Atibalentja, MD, PhD
Instructor, Medicine - Oncology
BioDanielle F Atibalentja received her PhD in Immunology at Washington University in St Louis and her MD at UCSF School of medicine. She trained in Internal medicine at Washington University/Barnes-Jewish Hospital in St Louis and recently completed Hematology/Oncology Fellowship at Stanford. Her primary clinical interest is in treating patients with B-cell lymphomas. Her long-term research goals are to better understand B-cell responses in the setting of malignancy to develop immune-based therapies for cancer treatment. She currently studies how the MYC oncogene shapes B-cell and antibody responses during T-cell lymphomagenesis.
-
Ashish Atreja
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioI work at the intersection of health care technology and artificial intelligence. My primary clinical specialty is Gastroenterology and my focus on AI is broad application and validation of clinical AI across diverse use cases.
After completing a master's in public health at the University of Illinois at Chicago, I have completed internal medicine residency, informatics fellowship, and gastroenterology fellowship at the Cleveland Clinic. I have been working at the intersection of technology and healthcare for the last 25 years, was the first gastroenterologist to receive informatics board certification. In leadership roles, I have led Epic implementations as informaticist, served as the Chief Innovation Officer, Medicine at Mount Sinai, New York, and most recently as CIO and inaugural Chief Digital Health Officer at UC Davis Health. For my executive roles, I have been recognized with numerous national honors, including being named one of the Top Digital Health Officers by Becker’s, a Top 40 Healthcare Transformer in 2017, a Top 50 Healthcare Leader by HIMSS in 2021, a Top 30 Health IT Influencer by Health Tech Magazine in 2022, a Top 150 Business Transformer Across global industries by Constellation Research and a top 35 Digital Health officer by Beckers in 2023.
As a digital health entrepreneur, I have successfully licensed technologies, and founded companies originating from academic medical centers. I was the co-founder of Rx.Health, a venture-backed spinout from Mount Sinai Health System that automated digital care delivery for major organizations including UnitedHealthcare and five of the top ten health systems in the U.S., ultimately impacting over 90 million patient lives before its successful acquisition. As a co-founder of GenServe.AI, I am currently working with a team focused on democratizing access to secure Generative AI and autonomous care for all.
I have been NIH-funded since 2014, including for IBD digital monitoring, have published more than 108 peer-reviewed articles and delivered over 250 posters, abstracts, and talks at national meetings. My research focuses on building, implementing, and evaluating digital health and AI-powered solutions aimed at improving patient and population outcomes, for which I am also known as the "App Doctor."
